Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Immuno-Oncology Webinar: Different Routes To The Same Destination

This article was originally published in Scrip

Executive Summary

Bristol-Myers Squibb has shot out of the starting gate in the great immuno-oncology race, with Merck & Co hot on its tail. Frenzied deal making and exponential growth in the number of investigational products and clinical trials taking place suggest, however, that there is ample room for a range of players in this market.